Biohaven eyes mid-2021 for migraine prevention drug launch
November 18, 2020 at 20:14 PM EST
"I hope that in 6 months or so from now that we will be the first oral CGRP with the indication for the prevention of migraine," Biohaven CEO Vlad Coric said.
